Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study

Abstract Background Adiposity is a strong risk factor for cancer incidence and mortality. However, most of the evidence available has focused on body mass index (BMI) as a marker of adiposity. There is limited evidence on relationships of cancer with other adiposity markers, and if these association...

Full description

Bibliographic Details
Main Authors: Solange Parra-Soto, Emma S. Cowley, Leandro F. M. Rezende, Catterina Ferreccio, John C. Mathers, Jill P. Pell, Frederick K. Ho, Carlos Celis-Morales
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12916-020-01848-8
_version_ 1818383336995815424
author Solange Parra-Soto
Emma S. Cowley
Leandro F. M. Rezende
Catterina Ferreccio
John C. Mathers
Jill P. Pell
Frederick K. Ho
Carlos Celis-Morales
author_facet Solange Parra-Soto
Emma S. Cowley
Leandro F. M. Rezende
Catterina Ferreccio
John C. Mathers
Jill P. Pell
Frederick K. Ho
Carlos Celis-Morales
author_sort Solange Parra-Soto
collection DOAJ
description Abstract Background Adiposity is a strong risk factor for cancer incidence and mortality. However, most of the evidence available has focused on body mass index (BMI) as a marker of adiposity. There is limited evidence on relationships of cancer with other adiposity markers, and if these associations are linear or not. The aim of this study was to investigate the associations of six adiposity markers with incidence and mortality from 24 cancers by accounting for potential non-linear associations. Methods A total of 437,393 participants (53.8% women; mean age 56.3 years) from the UK Biobank prospective cohort study were included in this study. The median follow-up was 8.8 years (interquartile range 7.9 to 9.6) for mortality and 9.3 years (IQR 8.6 to 9.9) for cancer incidence. Adiposity-related exposures were BMI, body fat percentage, waist-hip ratio, waist-height ratio, and waist and hip circumference. Incidence and mortality of 24 cancers sites were the outcomes. Cox proportional hazard models were used with each of the exposure variables fitted separately on penalised cubic splines. Results During follow-up, 47,882 individuals developed cancer and 11,265 died due to cancer during the follow-up period. All adiposity markers had similar associations with overall cancer incidence. BMI was associated with a higher incidence of 10 cancers (stomach cardia (hazard ratio per 1 SD increment 1.35, (95% CI 1.23; 1.47)), gallbladder (1.33 (1.12; 1.58)), liver (1.27 (1.19; 1.36)), kidney (1.26 (1.20; 1.33)), pancreas (1.12 (1.06; 1.19)), bladder (1.09 (1.04; 1.14)), colorectal (1.10 (1.06; 1.13)), endometrial (1.73 (1.65; 1.82)), uterine (1.68 (1.60; 1.75)), and breast cancer (1.08 (1.05; 1.11))) and overall cancer (1.03 (1.02; 1.04)). All these associations were linear except for breast cancer in postmenopausal women. Similar results were observed when other markers of central and overall adiposity were used. For mortality, nine cancer sites were linearly associated with BMI and eight with waist circumference and body fat percentage. Conclusion Adiposity, regardless of the marker used, was associated with an increased risk in 10 cancer sites.
first_indexed 2024-12-14T03:04:45Z
format Article
id doaj.art-6e4ad81efbad4c9dad295b5c0fa91bb0
institution Directory Open Access Journal
issn 1741-7015
language English
last_indexed 2024-12-14T03:04:45Z
publishDate 2021-01-01
publisher BMC
record_format Article
series BMC Medicine
spelling doaj.art-6e4ad81efbad4c9dad295b5c0fa91bb02022-12-21T23:19:25ZengBMCBMC Medicine1741-70152021-01-0119111410.1186/s12916-020-01848-8Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort studySolange Parra-Soto0Emma S. Cowley1Leandro F. M. Rezende2Catterina Ferreccio3John C. Mathers4Jill P. Pell5Frederick K. Ho6Carlos Celis-Morales7Institute of Health and Wellbeing, University of GlasgowInstitute of Cardiovascular and Medical Sciences, University of GlasgowDepartamento de Medicina Preventiva, Universidade Federal de São Paulo, Escola Paulista de MedicinaAdvanced Center for Chronic Diseases, Universidad de Chile and Pontificia Universidad Católica de ChileHuman Nutrition Research Centre, Population Health Sciences Institute, Newcastle UniversityInstitute of Health and Wellbeing, University of GlasgowInstitute of Health and Wellbeing, University of GlasgowInstitute of Health and Wellbeing, University of GlasgowAbstract Background Adiposity is a strong risk factor for cancer incidence and mortality. However, most of the evidence available has focused on body mass index (BMI) as a marker of adiposity. There is limited evidence on relationships of cancer with other adiposity markers, and if these associations are linear or not. The aim of this study was to investigate the associations of six adiposity markers with incidence and mortality from 24 cancers by accounting for potential non-linear associations. Methods A total of 437,393 participants (53.8% women; mean age 56.3 years) from the UK Biobank prospective cohort study were included in this study. The median follow-up was 8.8 years (interquartile range 7.9 to 9.6) for mortality and 9.3 years (IQR 8.6 to 9.9) for cancer incidence. Adiposity-related exposures were BMI, body fat percentage, waist-hip ratio, waist-height ratio, and waist and hip circumference. Incidence and mortality of 24 cancers sites were the outcomes. Cox proportional hazard models were used with each of the exposure variables fitted separately on penalised cubic splines. Results During follow-up, 47,882 individuals developed cancer and 11,265 died due to cancer during the follow-up period. All adiposity markers had similar associations with overall cancer incidence. BMI was associated with a higher incidence of 10 cancers (stomach cardia (hazard ratio per 1 SD increment 1.35, (95% CI 1.23; 1.47)), gallbladder (1.33 (1.12; 1.58)), liver (1.27 (1.19; 1.36)), kidney (1.26 (1.20; 1.33)), pancreas (1.12 (1.06; 1.19)), bladder (1.09 (1.04; 1.14)), colorectal (1.10 (1.06; 1.13)), endometrial (1.73 (1.65; 1.82)), uterine (1.68 (1.60; 1.75)), and breast cancer (1.08 (1.05; 1.11))) and overall cancer (1.03 (1.02; 1.04)). All these associations were linear except for breast cancer in postmenopausal women. Similar results were observed when other markers of central and overall adiposity were used. For mortality, nine cancer sites were linearly associated with BMI and eight with waist circumference and body fat percentage. Conclusion Adiposity, regardless of the marker used, was associated with an increased risk in 10 cancer sites.https://doi.org/10.1186/s12916-020-01848-8ObesityBody mass indexWaist circumferenceBody fatCancerUK Biobank
spellingShingle Solange Parra-Soto
Emma S. Cowley
Leandro F. M. Rezende
Catterina Ferreccio
John C. Mathers
Jill P. Pell
Frederick K. Ho
Carlos Celis-Morales
Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study
BMC Medicine
Obesity
Body mass index
Waist circumference
Body fat
Cancer
UK Biobank
title Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study
title_full Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study
title_fullStr Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study
title_full_unstemmed Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study
title_short Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study
title_sort associations of six adiposity related markers with incidence and mortality from 24 cancers findings from the uk biobank prospective cohort study
topic Obesity
Body mass index
Waist circumference
Body fat
Cancer
UK Biobank
url https://doi.org/10.1186/s12916-020-01848-8
work_keys_str_mv AT solangeparrasoto associationsofsixadiposityrelatedmarkerswithincidenceandmortalityfrom24cancersfindingsfromtheukbiobankprospectivecohortstudy
AT emmascowley associationsofsixadiposityrelatedmarkerswithincidenceandmortalityfrom24cancersfindingsfromtheukbiobankprospectivecohortstudy
AT leandrofmrezende associationsofsixadiposityrelatedmarkerswithincidenceandmortalityfrom24cancersfindingsfromtheukbiobankprospectivecohortstudy
AT catterinaferreccio associationsofsixadiposityrelatedmarkerswithincidenceandmortalityfrom24cancersfindingsfromtheukbiobankprospectivecohortstudy
AT johncmathers associationsofsixadiposityrelatedmarkerswithincidenceandmortalityfrom24cancersfindingsfromtheukbiobankprospectivecohortstudy
AT jillppell associationsofsixadiposityrelatedmarkerswithincidenceandmortalityfrom24cancersfindingsfromtheukbiobankprospectivecohortstudy
AT frederickkho associationsofsixadiposityrelatedmarkerswithincidenceandmortalityfrom24cancersfindingsfromtheukbiobankprospectivecohortstudy
AT carloscelismorales associationsofsixadiposityrelatedmarkerswithincidenceandmortalityfrom24cancersfindingsfromtheukbiobankprospectivecohortstudy